LAVA Therapeutics N.V.
NASDAQ:LVTX
1.68 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Assets: | |||||
| Current Assets: | |||||
| Cash & Cash Equivalents
| 44.231 | 100.333 | 151.014 | 19.429 | 8.326 |
| Short Term Investments
| 51.34 | 32.535 | 47.995 | 0 | 0 |
| Cash and Short Term Investments
| 95.571 | 132.868 | 151.014 | 19.429 | 8.326 |
| Net Receivables
| 1.699 | 3.254 | 0.832 | 1.815 | 0.25 |
| Inventory
| 0 | 0 | -48.827 | 0.997 | 0 |
| Other Current Assets
| 1.627 | 4.411 | 51.738 | 0.143 | 0 |
| Total Current Assets
| 98.897 | 140.533 | 154.757 | 22.384 | 8.646 |
| Non-Current Assets: | |||||
| Property, Plant & Equipment, Net
| 2.494 | 2.083 | 2.206 | 1.836 | 1.301 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.319 | 0.809 | 0.902 | 0.944 | 0.034 |
| Total Non-Current Assets
| 2.813 | 2.892 | 3.109 | 2.78 | 1.335 |
| Total Assets
| 101.71 | 143.425 | 157.866 | 25.164 | 9.981 |
| Liabilities & Equity: | |||||
| Current Liabilities: | |||||
| Account Payables
| 4.446 | 3.965 | 2.894 | 1.146 | 0.479 |
| Short Term Debt
| 5.722 | 5.019 | 0.296 | 0.253 | 0.268 |
| Tax Payables
| 0 | 0.045 | 0 | 0 | 0 |
| Deferred Revenue
| 4.291 | 35 | 1.731 | 5.355 | 0.853 |
| Other Current Liabilities
| 0.482 | -22.03 | 0.103 | 2.054 | 0.016 |
| Total Current Liabilities
| 14.941 | 21.954 | 5.025 | 8.809 | 1.616 |
| Non-Current Liabilities: | |||||
| Long Term Debt
| 0.591 | 0.431 | 5.516 | 4.76 | 1.735 |
| Deferred Revenue Non-Current
| 35 | 35 | 1.731 | 2.232 | 0 |
| Deferred Tax Liabilities Non-Current
| -35 | -4.732 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 4.732 | 11.401 | 0 | 0 |
| Total Non-Current Liabilities
| 35.591 | 35.431 | 18.647 | 6.993 | 1.735 |
| Total Liabilities
| 50.532 | 57.385 | 23.672 | 15.802 | 3.35 |
| Equity: | |||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 3.715 | 3.715 | 4.141 | 0 | 0 |
| Retained Earnings
| -148.067 | -108.069 | -89.26 | -44.355 | -15.549 |
| Accumulated Other Comprehensive Income/Loss
| 1.106 | -4.03 | 1.334 | 0.685 | -0.015 |
| Other Total Stockholders Equity
| 194.424 | 194.424 | 217.979 | 53.033 | 22.194 |
| Total Shareholders Equity
| 51.178 | 86.04 | 134.194 | 9.362 | 6.631 |
| Total Equity
| 51.178 | 86.04 | 134.194 | 9.362 | 6.631 |
| Total Liabilities & Shareholders Equity
| 101.71 | 143.425 | 157.866 | 25.164 | 9.981 |